Diogo Mendes

1.1k total citations
40 papers, 796 citations indexed

About

Diogo Mendes is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Diogo Mendes has authored 40 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Toxicology, 11 papers in Pediatrics, Perinatology and Child Health and 8 papers in Oncology. Recurrent topics in Diogo Mendes's work include Pharmacovigilance and Adverse Drug Reactions (13 papers), Pharmaceutical studies and practices (10 papers) and Drug-Induced Adverse Reactions (6 papers). Diogo Mendes is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (13 papers), Pharmaceutical studies and practices (10 papers) and Drug-Induced Adverse Reactions (6 papers). Diogo Mendes collaborates with scholars based in Portugal, United Kingdom and Sweden. Diogo Mendes's co-authors include Carlos Alves, Francisco Batel Marques, Fátima Cardoso, Luís Costa, José Luís Passos‐Coelho, N. Afonso, Ariel Tessone, Antonio Alcaraz, Josep M. Campistol and Patrícia Dias and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and BMC Medicine.

In The Last Decade

Diogo Mendes

38 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diogo Mendes Portugal 16 129 116 100 96 92 40 796
Francisco Batel Marques Portugal 22 231 1.8× 321 2.8× 212 2.1× 172 1.8× 271 2.9× 91 1.5k
Sophie Fédrizzi France 13 358 2.8× 76 0.7× 73 0.7× 57 0.6× 65 0.7× 49 727
Juan Cosı́n-Sales Spain 22 101 0.8× 94 0.8× 317 3.2× 38 0.4× 26 0.3× 94 1.6k
Steven T. Bird United States 16 68 0.5× 62 0.5× 69 0.7× 48 0.5× 18 0.2× 31 736
Greg Carney Canada 12 75 0.6× 118 1.0× 45 0.5× 36 0.4× 12 0.1× 37 620
Martin Quinn Ireland 19 76 0.6× 110 0.9× 643 6.4× 102 1.1× 50 0.5× 45 1.6k
Mo Dimbil United States 6 41 0.3× 37 0.3× 83 0.8× 53 0.6× 144 1.6× 7 455
Weng-Foung Huang Taiwan 16 104 0.8× 82 0.7× 92 0.9× 59 0.6× 9 0.1× 27 568
Mugdha Gokhale United States 14 122 0.9× 73 0.6× 92 0.9× 19 0.2× 13 0.1× 31 603
G. Aulagner France 18 119 0.9× 126 1.1× 110 1.1× 125 1.3× 12 0.1× 79 1.2k

Countries citing papers authored by Diogo Mendes

Since Specialization
Citations

This map shows the geographic impact of Diogo Mendes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diogo Mendes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diogo Mendes more than expected).

Fields of papers citing papers by Diogo Mendes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diogo Mendes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diogo Mendes. The network helps show where Diogo Mendes may publish in the future.

Co-authorship network of co-authors of Diogo Mendes

This figure shows the co-authorship network connecting the top 25 collaborators of Diogo Mendes. A scholar is included among the top collaborators of Diogo Mendes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diogo Mendes. Diogo Mendes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alves, Carlos, et al.. (2023). The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies. International Journal of Clinical Pharmacy. 46(2). 357–367. 3 indexed citations
2.
Alves, Carlos, et al.. (2023). Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis. International Journal of Clinical Pharmacy. 45(4). 830–838. 4 indexed citations
3.
Ribeiro, Inês, et al.. (2023). Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis. BMC Women s Health. 23(1). 96–96. 2 indexed citations
4.
Mendes, Diogo, et al.. (2023). Impact of the COVID-19 pandemic on cancer screenings in Portugal. Cancer Epidemiology. 88. 102496–102496.
5.
Alves, Carlos, et al.. (2022). The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis. European Journal of Clinical Pharmacology. 78(12). 1923–1933. 19 indexed citations
6.
Alves, Carlos, et al.. (2021). The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 28(2). e407–e414. 35 indexed citations
7.
Custódio, Cláudia, et al.. (2021). Information Frictions and Firm Take up of Government Support: A Randomised Controlled Experiment. SSRN Electronic Journal. 1 indexed citations
9.
Mendes, Diogo, et al.. (2020). Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients. SHILAP Revista de lepidopterología. 8(12). 3431–3438. 8 indexed citations
10.
Mendes, Diogo, et al.. (2019). Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis. European Thyroid Journal. 8(3). 130–143. 67 indexed citations
11.
Mendes, Diogo, et al.. (2019). Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital. Journal of Oncology Pharmacy Practice. 26(1). 133–140. 4 indexed citations
12.
Mendes, Diogo, et al.. (2018). Drug-induced hypersensitivity: A 5-year retrospective study in a hospital electronic health records database. Journal of Clinical Pharmacy and Therapeutics. 44(1). 54–61. 6 indexed citations
13.
Alves, Carlos, Diogo Mendes, & Francisco Batel Marques. (2018). Statins and risk of cataracts: A systematic review and meta‐analysis of observational studies. Cardiovascular Therapeutics. 36(6). e12480–e12480. 12 indexed citations
14.
Mendes, Diogo, Carlos Alves, & Francisco Batel Marques. (2017). Number needed to treat (NNT) in clinical literature: an appraisal. BMC Medicine. 15(1). 112–112. 121 indexed citations
16.
Alves, Carlos, et al.. (2016). Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis. Ophthalmic Research. 57(1). 60–69. 14 indexed citations
17.
Mendes, Diogo, Carlos Alves, N. Afonso, et al.. (2015). The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review. Breast Cancer Research. 17(1). 140–140. 143 indexed citations
18.
Mendes, Diogo, et al.. (2015). Drug-Induced Ocular Adverse Reactions: Review of the Safety Alerts Issued During the Last Decade. Journal of Ocular Pharmacology and Therapeutics. 31(5). 258–268. 10 indexed citations
19.
Mendes, Diogo, et al.. (2014). Safety Monitoring of Ophthalmic Biologics: A Systematic Review of Pre- and Postmarketing Safety Data. Journal of Ocular Pharmacology and Therapeutics. 30(9). 729–751. 16 indexed citations
20.
Haik, Josef, et al.. (2005). Burn care standards in Israel: Lack of consensus. Burns. 31(7). 845–849. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026